• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

黄连-厚朴药对的研究进展:化学成分、药理作用及药代动力学分析。

A Comprehensive Review of Coptidis Rhizoma and Magnoliae Officinalis Cortex Drug Pair and Their Chemical Composition, Pharmacological Effects and Pharmacokinetics Analysis.

机构信息

School of Medicine, Foshan University, Foshan, 528000, People's Republic of China.

出版信息

Drug Des Devel Ther. 2024 Oct 2;18:4413-4426. doi: 10.2147/DDDT.S477381. eCollection 2024.

DOI:10.2147/DDDT.S477381
PMID:39372674
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11456271/
Abstract

Herbal pairs are unique combinations of two relatively fixed herbs that are used in clinical practice. This is the most fundamental and straightforward form of multiple herbal treatment that aims to attain specific efficacy through unique methods. Coptidis Rhizoma ("Huanglian" in Chinese) and Magnoliae Officinalis Cortex ("Houpo" in Chinese) which are commonly used in combination and could also be used as important components of other prescriptions to treat damp-heat dysentery, splenic and stomach disorders, and qi stagnation in clinical practice. However, there is currently no summary on the compatibility of Huanglian and Houpo about traditional use, phytochemistry, and pharmacological activity. It was found the combination or separate extraction of the two drugs may affect the main active components, and new components may be produced after the combined extraction. At the same time, Huanglian and Houpo herb pair exhibited antiviral, anti-inflammatory, antibacterial and other pharmacological effects. At present, research mainly focuses on the indicator components of Huanglian and Houpo, such as berberine, magnolol, and magnolol. The models used for pharmacological validation are limited, mainly including ulcerative colitis, pneumonia, bacterial infections, etc. In order to verify the pharmacological activity of the combination of Huanglian and Houpo, it is necessary to try more in vitro and in vivo models. It's still need to study the compatibility mechanism of the Huanglian and Houpo drug pair, including but not limited to the interactions between different components and the impact of compatibility on efficacy, bioequivalence studies, and the impact of different dosage forms on pharmacokinetics in the future. It's believed that the systematic review provided comprehensive information for the study of Huanglian-Houpo drug pair, which will help highlight the importance of the Huanglian-Houpo herb pair and provide some clues for future research on this herb pair.

摘要

草药对药是指临床使用的两种相对固定的草药的独特组合。这是多种草药治疗中最基本和直接的形式,旨在通过独特的方法达到特定的疗效。黄连和厚朴在临床上常被组合使用,也可作为其他方剂的重要组成部分,用于治疗湿热痢疾、脾胃不和、气滞等病症。然而,目前关于黄连和厚朴的传统应用、植物化学和药理活性的综合信息尚未报道。研究发现,两药合用或分别提取可能会影响主要活性成分,联合提取后可能会产生新的成分。同时,黄连和厚朴药对表现出抗病毒、抗炎、抗菌等药理作用。目前,研究主要集中在黄连和厚朴的指标成分,如小檗碱、厚朴酚、和和厚朴酚等。药理验证的模型有限,主要包括溃疡性结肠炎、肺炎、细菌感染等。为了验证黄连和厚朴组合的药理活性,有必要尝试更多的体外和体内模型。仍需研究黄连和厚朴药对的配伍机制,包括但不限于不同成分之间的相互作用以及配伍对疗效的影响、生物等效性研究以及不同剂型对药代动力学的影响等。相信本综述为黄连-厚朴药对的研究提供了全面的信息,有助于突出黄连-厚朴药对的重要性,并为今后对该药对的研究提供一些线索。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/429b/11456271/9cbbe0e6233f/DDDT-18-4413-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/429b/11456271/3d1aed0be728/DDDT-18-4413-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/429b/11456271/82bddd680b06/DDDT-18-4413-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/429b/11456271/d7c8978d85e6/DDDT-18-4413-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/429b/11456271/968c6b223e07/DDDT-18-4413-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/429b/11456271/9cbbe0e6233f/DDDT-18-4413-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/429b/11456271/3d1aed0be728/DDDT-18-4413-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/429b/11456271/82bddd680b06/DDDT-18-4413-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/429b/11456271/d7c8978d85e6/DDDT-18-4413-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/429b/11456271/968c6b223e07/DDDT-18-4413-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/429b/11456271/9cbbe0e6233f/DDDT-18-4413-g0005.jpg

相似文献

1
A Comprehensive Review of Coptidis Rhizoma and Magnoliae Officinalis Cortex Drug Pair and Their Chemical Composition, Pharmacological Effects and Pharmacokinetics Analysis.黄连-厚朴药对的研究进展:化学成分、药理作用及药代动力学分析。
Drug Des Devel Ther. 2024 Oct 2;18:4413-4426. doi: 10.2147/DDDT.S477381. eCollection 2024.
2
A review of the phytochemistry and pharmacological activities of Magnoliae officinalis cortex.厚朴的植化成分和药理活性研究综述。
J Ethnopharmacol. 2019 May 23;236:412-442. doi: 10.1016/j.jep.2019.02.041. Epub 2019 Feb 25.
3
Pharmacokinetics and Pharmacodynamics of Huanglian-Houpo Decoction Based on Berberine Hydrochloride and Magnolol Against H1N1 Influenza Virus.基于盐酸小檗碱和厚朴酚的黄连-厚朴汤对 H1N1 流感病毒的药代动力学和药效学研究。
Eur J Drug Metab Pharmacokinet. 2022 Jan;47(1):57-67. doi: 10.1007/s13318-021-00724-x. Epub 2021 Oct 12.
4
Herb pairs containing Curcumae Rhizoma (Ezhu): A review of bio-active constituents, compatibility effects and t-copula function analysis.含莪术的药对:生物活性成分、配伍作用及 t 型 copula 函数分析的综述。
J Ethnopharmacol. 2024 Jan 30;319(Pt 3):117199. doi: 10.1016/j.jep.2023.117199. Epub 2023 Oct 14.
5
Berberine and Coptidis rhizoma as novel antineoplastic agents: a review of traditional use and biomedical investigations.小檗碱和黄连作为新型抗肿瘤药物:传统应用和生物医学研究综述。
J Ethnopharmacol. 2009 Oct 29;126(1):5-17. doi: 10.1016/j.jep.2009.08.009. Epub 2009 Aug 15.
6
Coptidis Rhizoma: a comprehensive review of its traditional uses, botany, phytochemistry, pharmacology and toxicology.黄连:传统用途、植物学、植物化学、药理学和毒理学的综合评价。
Pharm Biol. 2019 Dec;57(1):193-225. doi: 10.1080/13880209.2019.1577466.
7
Pharmacokinetic incompatibility of the Huanglian-Gancao herb pair.黄连-甘草药对的药代动力学不相容性。
BMC Complement Med Ther. 2020 Feb 22;20(1):61. doi: 10.1186/s12906-020-2845-5.
8
Tracking evidences of Coptis chinensis for the treatment of inflammatory bowel disease from pharmacological, pharmacokinetic to clinical studies.从药理学、药代动力学到临床研究追踪黄连治疗炎症性肠病的证据。
J Ethnopharmacol. 2021 Mar 25;268:113573. doi: 10.1016/j.jep.2020.113573. Epub 2020 Nov 9.
9
Several major herb pairs containing : a review of key traditional uses, constituents and compatibility effects.几种主要药对包含:关键传统用途、成分及配伍效应综述
Front Pharmacol. 2024 Jun 25;15:1399460. doi: 10.3389/fphar.2024.1399460. eCollection 2024.
10
Multi-omics combined to explore the purging mechanism of Rhei Radix et Rhizoma and Magnoliae Officinalis Cortex.多组学联合探究大黄和肉桂的减毒机制。
J Chromatogr B Analyt Technol Biomed Life Sci. 2024 Aug 1;1243:124218. doi: 10.1016/j.jchromb.2024.124218. Epub 2024 Jun 28.

本文引用的文献

1
Contemporary strategies and approaches for characterizing composition and enhancing biofilm penetration targeting bacterial extracellular polymeric substances.用于表征组成并增强针对细菌细胞外聚合物的生物膜穿透的当代策略和方法。
J Pharm Anal. 2024 Apr;14(4):100906. doi: 10.1016/j.jpha.2023.11.013. Epub 2023 Nov 29.
2
Traditional Chinese Medicine: A promising strategy to regulate the imbalance of bacterial flora, impaired intestinal barrier and immune function attributed to ulcerative colitis through intestinal microecology.中医药:通过肠道微生态调节溃疡性结肠炎细菌菌群失衡、肠屏障损伤及免疫功能紊乱的策略
J Ethnopharmacol. 2024 Jan 10;318(Pt A):116879. doi: 10.1016/j.jep.2023.116879. Epub 2023 Jul 5.
3
Identification of the therapeutic effect and molecular mechanism of Coptis chinensis Franch. and Magnolia officinalis var. biloba on chronic gastritis.
黄连和厚朴对慢性胃炎的治疗作用及分子机制的鉴定。
J Ethnopharmacol. 2023 Dec 5;317:116864. doi: 10.1016/j.jep.2023.116864. Epub 2023 Jun 29.
4
Comparison of pharmacological activity and safety of different stereochemical configurations of borneol: L-borneol, D-borneol, and synthetic borneol.比较不同立体化学构型龙脑(L-龙脑、D-龙脑和合成龙脑)的药理学活性和安全性。
Biomed Pharmacother. 2023 Aug;164:114668. doi: 10.1016/j.biopha.2023.114668. Epub 2023 Jun 13.
5
Gut microbiome, metabolome, host immunity associated with inflammatory bowel disease and intervention of fecal microbiota transplantation.肠道微生物组、代谢组、宿主免疫与炎症性肠病的关系及粪便微生物移植的干预作用。
J Autoimmun. 2023 Dec;141:103062. doi: 10.1016/j.jaut.2023.103062. Epub 2023 May 27.
6
Oral administration of Huanglian-Houpo herbal nanoemulsion loading multiple phytochemicals for ulcerative colitis therapy in mice.黄连-厚朴药纳米乳载多植物化学物经口给药治疗溃疡性结肠炎的小鼠研究
Drug Deliv. 2023 Dec;30(1):2204207. doi: 10.1080/10717544.2023.2204207.
7
Huanglian-Houpo extract attenuates DSS-induced UC mice by protecting intestinal mucosal barrier and regulating macrophage polarization.黄连-厚朴提取物通过保护肠道黏膜屏障和调节巨噬细胞极化来减轻 DSS 诱导的 UC 小鼠的病情。
J Ethnopharmacol. 2023 May 10;307:116181. doi: 10.1016/j.jep.2023.116181. Epub 2023 Feb 2.
8
Multimodal integrated strategy for the discovery and identification of quality markers in traditional Chinese medicine.用于发现和鉴定中药质量标志物的多模态整合策略
J Pharm Anal. 2022 Oct;12(5):701-710. doi: 10.1016/j.jpha.2022.05.001. Epub 2022 May 16.
9
The Gut-Immune-Brain Axis: An Important Route for Neuropsychiatric Morbidity in Inflammatory Bowel Disease.肠道-免疫-脑轴:炎症性肠病神经精神发病机制的重要途径
Int J Mol Sci. 2022 Sep 21;23(19):11111. doi: 10.3390/ijms231911111.
10
Interactions between gut microbiota and berberine, a necessary procedure to understand the mechanisms of berberine.肠道微生物群与小檗碱之间的相互作用,这是了解小檗碱作用机制的必要过程。
J Pharm Anal. 2022 Aug;12(4):541-555. doi: 10.1016/j.jpha.2021.10.003. Epub 2021 Oct 21.